ImageneBio, Inc. (IMA)
4.165
+0.06
(+1.59%)
USD |
NASDAQ |
Nov 05, 16:00
ImageneBio Debt to Equity Ratio : 0.0315 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0315 |
| March 31, 2026 | 0.0661 |
| December 31, 2025 | 0.0751 |
| September 30, 2025 | 0.0783 |
| June 30, 2025 | 0.049 |
| March 31, 2025 | 0.0559 |
| December 31, 2024 | -5.274 |
| September 30, 2024 | 0.0625 |
| June 30, 2024 | 0.0636 |
| March 31, 2024 | 0.0627 |
| December 31, 2023 | 0.0633 |
| September 30, 2023 | 0.0614 |
| June 30, 2023 | 0.0319 |
| March 31, 2023 | 0.0396 |
| Date | Value |
|---|---|
| December 31, 2022 | 0.0387 |
| September 30, 2022 | 0.038 |
| June 30, 2022 | 0.0365 |
| March 31, 2022 | 0.0346 |
| December 31, 2021 | 0.0336 |
| September 30, 2021 | 0.0359 |
| June 30, 2021 | 0.0351 |
| March 31, 2021 | 0.0335 |
| December 31, 2020 | -2.040 |
| September 30, 2020 | -1.010 |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | -1.283 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0413 |
| Alnylam Pharmaceuticals, Inc. | 0.8316 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
| Vericel Corp. | 0.2556 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 152.04M |
| Total Liabilities (Quarterly) | 9.971M |
| Shareholders Equity (Quarterly) | 142.07M |
| Current Ratio | 21.47 |
| Net Debt Paydown Yield | 0.64% |